AMANDA COLABELLO: Open Payments
NPI 1407427453 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 38 payments from 11 companies in 2025. Trend: 2023 $706 · 2024 $502 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $228 |
| SCPHARMACEUTICALS INC. | 7 | $119 |
| Alnylam Pharmaceuticals Inc. | 6 | $98 |
| Actelion Pharmaceuticals US, Inc. | 5 | $74 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| PFIZER INC. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21 |
Products named: JARDIANCE, FUROSCIX, ONPATTRO, UPTRAVI, NEXLETOL, ELIQUIS, LEQVIO, VERQUVO.
Industry payments across NY — which companies pay providers there.
